Sterilance Medical

Sterilance Medical was founded in 1993 and is committed to providing global partners with professional series of end blood collection devices and surgical instruments, so that patients can obtain safer, more reliable, comfortable and convenient product experience. Sterilance Medical is also a solution provider, providing customers and partners with a full range of solutions from concept design to final product formation. As a national high-tech enterprise, as of the third quarter of 2023, Sterilance has more than 160 domestic and foreign patents, and has passed the international ISO13485 quality management system certification, China Drug Administration medical device registration and EU CE certification (MDR), the United States FDA510k certification and other strict product certification. Sterilance realizes convenient and stable product performance with its ingenious design capabilities, automation experience and comprehensive quality management system, so as to obtain the recognition of customers and the majority of medical staff and patients. Sterilance product sales and service network covers most parts of the country, and is sold to more than 50 countries and regions in Asia Pacific, Europe and the United States, South America, the Middle East and so on. In the future, Sterilance will use 30 years of design and development, precision injection molding, automation application and supply chain advantages to provide customers and users with needle and knife medical consumables at reasonable costs and product combinations to help medical staff improve operational efficiency, reduce the risk of cross-infection, and improve treatment outcomes. Mr. Shi Yinggan, the founder, interpreted Sterilance SteriLance: